367 related articles for article (PubMed ID: 24085572)
41. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
Belsito DV
J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
[TBL] [Abstract][Full Text] [Related]
42. Management of chronic spontaneous urticaria in real life--in accordance with the guidelines? A cross-sectional physician-based survey study.
Weller K; Viehmann K; Bräutigam M; Krause K; Siebenhaar F; Zuberbier T; Maurer M
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):43-50. PubMed ID: 22150693
[TBL] [Abstract][Full Text] [Related]
43. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
44. Current and future therapies for treating chronic spontaneous urticaria.
Maurer M; Vena GA; Cassano N; Zuberbier T
Expert Opin Pharmacother; 2016 Jun; 17(8):1131-9. PubMed ID: 26918673
[TBL] [Abstract][Full Text] [Related]
45. Clinical practice guideline for diagnosis and management of urticaria.
Kulthanan K; Tuchinda P; Chularojanamontri L; Chanyachailert P; Korkij W; Chunharas A; Wananukul S; Limpongsanurak W; Benjaponpitak S; Wisuthsarewong W; Aunhachoke K; Wessagowit V; Chatchatee P; Wattanakrai P; Jirapongsananuruk O; Klaewsongkram J; Noppakun N; Vichyanond P; Suthipinittharm P; Ruxrungtham K; Singalavanija S; Ngamphaiboon J
Asian Pac J Allergy Immunol; 2016 Sep; 34(3):190-200. PubMed ID: 27690471
[TBL] [Abstract][Full Text] [Related]
46. Critical appraisal of the unmet needs in the treatment of chronic spontaneous urticaria with omalizumab: an Italian perspective.
Asero R; Canonica GW; Cristaudo A; Fierro MT; Girolomoni G; Marzano AV; Nettis E; Pepe P; Pigatto P; Rossi O
Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):453-459. PubMed ID: 28968274
[TBL] [Abstract][Full Text] [Related]
47. Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast.
Tedeschi A
Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):187-9. PubMed ID: 20128233
[TBL] [Abstract][Full Text] [Related]
48. [Chronic urticaria: which evaluation? Which management?].
Tas S
Rev Med Brux; 2008 Sep; 29(4):409-14. PubMed ID: 18949996
[TBL] [Abstract][Full Text] [Related]
49. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses.
Asero R
Clin Exp Dermatol; 2007 Jan; 32(1):34-8. PubMed ID: 17042777
[TBL] [Abstract][Full Text] [Related]
50. S3 Guideline Urticaria. Part 2: Treatment of urticaria - German-language adaptation of the international S3 guideline.
Zuberbier T; Altrichter S; Bauer S; Brehler R; Brockow K; Dressler C; Fluhr J; Gaskins M; Hamelmann E; Kühne K; Merk H; Mülleneisen NK; Nast A; Olze H; Ott H; Pleimes M; Ruëff F; Staubach-Renz P; Wedi B; Maurer M
J Dtsch Dermatol Ges; 2023 Feb; 21(2):202-215. PubMed ID: 36730626
[TBL] [Abstract][Full Text] [Related]
51. Therapy of antihistamine-resistant chronic spontaneous urticaria.
Greiwe J; Bernstein JA
Expert Rev Clin Immunol; 2017 Apr; 13(4):311-318. PubMed ID: 27744711
[TBL] [Abstract][Full Text] [Related]
52. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
[TBL] [Abstract][Full Text] [Related]
53. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg.
Giménez-Arnau A; Izquierdo I; Maurer M
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1088-91. PubMed ID: 19453774
[TBL] [Abstract][Full Text] [Related]
54. Update on the treatment of chronic urticaria.
Curto-Barredo L; Silvestre JF; Giménez-Arnau AM
Actas Dermosifiliogr; 2014 Jun; 105(5):469-82. PubMed ID: 23664252
[TBL] [Abstract][Full Text] [Related]
55. Urticaria.
Wedi B; Wieczorek D; Raap U; Kapp A
J Dtsch Dermatol Ges; 2014 Nov; 12(11):997-1007; quiz 1008-9. PubMed ID: 25273223
[TBL] [Abstract][Full Text] [Related]
56. Management of chronic spontaneous urticaria: practical parameters.
Marzano AV; Pigatto P; Cristaudo A; Ayala F; Rossi O; Senna G; Triggiani M; Asero R
G Ital Dermatol Venereol; 2015 Apr; 150(2):237-46. PubMed ID: 25714626
[TBL] [Abstract][Full Text] [Related]
57. Omalizumab for the treatment of chronic urticaria.
Zuberbier T; Maurer M
Expert Rev Clin Immunol; 2015 Feb; 11(2):171-80. PubMed ID: 25566680
[TBL] [Abstract][Full Text] [Related]
58. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults - Brazilian Society of Dermatology.
Criado PR; Maruta CW; Alchorne AOA; Ramos AMC; Gontijo B; Santos JBD; Martins LEAM; Rivitti-Machado MC; Silvares MRC; Pires MC; Souza PK; Orfali RL; Bonamigo RR; Bedrikow RB; Criado RFJ; Oliveira ZNP
An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):56-66. PubMed ID: 31166404
[TBL] [Abstract][Full Text] [Related]
59. Effect of antihistamine up-dosing in chronic urticaria.
Ferrer M; Sastre J; Jáuregui I; Dávila I; Montoro J; del Cuvillo A; Mullol J; Bartra J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():34-9. PubMed ID: 22185048
[TBL] [Abstract][Full Text] [Related]
60. What are the effects of omalizumab in refractory chronic spontaneous urticaria?
López M; Navajas-Galimany L
Medwave; 2015 Dec; 15 Suppl 3():e6346. PubMed ID: 26731420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
